This pilot study showed that the AndroidAPS system was a safe and feasible alternative to the SmartGuard Technology.
No takes yet. Share an insight, caveat, or question.
Petruželková et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: